SORBENTOGEL BABY

INSTRUCTIONS FOR MEDICAL USE OF THE MEDICINAL PRODUCT SORBENTOGEL BABY (SORBENTOGEL BABY)

Composition:

Active substance: methylsilicic acid hydrogel;

1 g of the preparation contains 0.7 g of methylsilic游戏副本

Pharmacological properties.

Pharmacodynamics.

An inert organosilicon compound. When administered, it exerts a sorption effect. The medicinal product effectively adsorbs medium-molecular toxic substances of exogenous and endogenous origin, products of incomplete metabolism, incorporated radionuclides, and naturally eliminates them from the body.

The drug improves detoxification functions of the intestine, liver, and kidneys, normalizes blood and urine parameters.

By coating the mucous membranes of the stomach and intestine, the drug protects them from erosive processes and promotes enhancement of local immunity.

Pharmacokin游戏副本ics.

The drug is not absorbed from the gastrointestinal tract and undergoes neither metabolic nor chemical transformations.

Clinical characteristics.

Indications.

As part of complex detoxification therapy in chronic renal failure; in toxic hepatitis, viral hepatitis A and B, liver cirrhosis and cholestasis of various etiologies; in enterocolitis, colitis, diarrhea, gastritis with reduced acidity, and in alcohol and narcotic poisoning; in allergic and skin diseases (diatheses, neurodermatitis); in burn intoxication; in purulent-septic and inflammatory processes accompanied by intoxication; as part of complex therapy for intestinal dysbiosis.

Contraindications.

Acute intestinal obstruction.

Interaction with other medicinal products and other forms of interaction.

The drug may reduce the effect of other medicinal products taken concurrently. Provided the recommended administration method is followed (other medicinal products are taken with an interval of 1.5–2 hours), the drug can be prescribed as part of combination therapy with other medicinal and prophylactic agents, including prebiotics and probiotics (bifidobacteria, lactobacilli), phytopreparations, adaptogens, and immunomodulators. Concomitant use with medicinal products belonging to the class of bile acid sequestrants, for example cholestyramine, is not recommended due to increased risk of constipation development.

The medicinal product should not be used together with silver-containing preparations.

Special precautions.

Use during pregnancy or breastfeeding.

The medicinal product is intended for use in children.

Ability to affect reaction speed when driving or operating machinery.

No effect.

Method of Administration and Dosage.

Take orally 3 times a day, 1.5–2 hours before or 2 hours after meals or taking other medications, washing down with sufficient amount of water.

For children aged 14 years and older: single dose is 15 g (tablespoon), daily dose is 45 g.

For children aged 5 to 14 years: single dose is 10 g (dessert spoon or 1 sachet of 10 g, or 2 sachets of 5 g), daily dose is 30 g.

For children from birth to 5 years of age: single dose is 5 g (teaspoon or 1 sachet of 5 g), daily dose is 15 g.

Treatment duration is 7 to 14 days.

In severe cases, double the single dose may be used during the first three days. In chronic conditions (chronic renal insufficiency), the drug may be administered for a longer period (up to 1 month).

Children.

The medicinal product can be used in children from birth. For children under 2 years of age, the single dose may be mixed with a small amount of water before administration.

Overdose.

Cases of overdose have not been reported.

In case of overdose, adverse effects may be intensified.

Side effects.

Gastrointestinal disturbances may occur during administration of the drug. Constipation may develop during the first days of treatment. To prevent constipation, patients prone to this condition should be administered a cleansing enema at night or laxatives (lactulose, sodium picosulfate) during the first two days of treatment.

Shelf life.

2 years from the date of manufacture of the drug in bulk packaging.

Storage conditions.

Store in the original packaging at a temperature not exceeding 25 °C.

Do not allow freezing. After freezing, the product loses its properties.

After opening the packaging, store under the same conditions in tightly closed containers.

Keep out of reach of children.

Packaging. 50 g in a tube in a box; 5 g or 10 g in sachets, pack of 20 in a box.

Availability. Over-the-counter (without prescription).

Manufacturer. Limited Liability Company "Pharmaceutical Company "Vertex".

Manufacturer's address and location of business activity.

33, Astronomichna Street, lit. B-1, Kharkiv, Kharkiv region, 61085, Ukraine.